ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P 500
5,872.16
-2.95%
US Tech 100
20,752.40
0.45%
Dow Jones
42,326.87
-2.58%
Brent Oil
72.91
0.24%
Bitcoin
102,233.18
2.17%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Cryptocurrencies
  4. COIN
  5. (Cryptocurrency:ALTGBP)

  6. (Cryptocurrency:ALTGBP) News

ALTGBP

(ALTGBP)

Unknown symbol
Date:
Sort by:
DateTimeSourceHeadlineSymbolCompany
12/19/20247:03AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:TUYATuya Inc
12/19/20247:02AMPR Newswire (US)Hamilton Zanze Sponsors the Acquisition of Reserve at Kirkwood
12/19/20247:01AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:LXEOLexeo Therapeutics Inc
12/19/20247:01AMBusiness WireGlobal Fintech and Financial Industry Enterprises Choose FiscalNote as Their Essential Partner to Navigate Complex Policy and Regulatory ChallengesNYSE:NOTEFiscaNote Holdings Inc
12/19/20247:00AMEdgar (US Regulatory)Form 8-K - Current reportAMEX:NBYNovaBay Pharmaceuticals Inc New
12/19/20247:00AMGlobeNewswire Inc.NGM Bio and KdT Ventures Enter into Worldwide License Agreement for NGM313, a Phase 2-ready FGFR1c/β-Klotho Agonist Drug Candidate
12/19/20247:00AMGlobeNewswire Inc.BexBack Futures Exchange: 100% Deposit Bonus and No KYC—The Freedom Every Trader Deserves
12/19/20247:00AMGlobeNewswire Inc.Lifecore Biomedical Selected by Nirsum Labs to Provide CDMO Services Supporting Clinical Development of Innovative Opioid Use Disorder TreatmentNASDAQ:LFCRLifecore Biomedical Inc
12/19/20247:00AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:KRNTKornit Digital Ltd
12/19/20247:00AMEdgar (US Regulatory)Form 8-K/A - Current report: [Amend]NYSE:SCLStepan Company
12/19/20247:00AMGlobeNewswire Inc.Regeneron to Advance Two Factor XI Antibodies into a Broad Phase 3 Program Following Positive Phase 2 Proof-of-concept ResultsNASDAQ:REGNRegeneron Pharmaceuticals Inc
12/19/20247:00AMGlobeNewswire Inc.NMD Pharma Announces Publication of Phase 1 Clinical Trial Data Evaluating NMD670 in Healthy Volunteers in the Journal Clinical Pharmacology & Therapeutics 
12/19/20247:00AMGlobeNewswire Inc.Lantronix to Present at the 27th Annual Needham Growth Conference on Jan. 14–15, 2025NASDAQ:LTRXLantronix Inc
12/19/20247:00AMGlobeNewswire Inc.PyroGenesis Announces Debt-to-Equity Conversion of Client Receivable8PY
12/19/20247:00AMBusiness WireAiwyn Secures $113M in Funding from KKR and Bessemer Venture Partners to Revolutionize Firm Operations and Tax Technology for Leading CPA FirmsNYSE:KKRKKR and Company Inc
12/19/20247:00AMGlobeNewswire Inc.Tilray Brands, Inc. to Announce Second Quarter Fiscal Year 2025 Financial Results on January 9, 2025TSX:TLRYTilray Brands Inc
12/19/20247:00AMBusiness WireVerde Clean Fuels, Inc. Announces $50 Million Equity Investment by Cottonmouth Ventures, LLC, a Wholly-Owned Subsidiary of Diamondback Energy, Inc.NASDAQ:VGASVerde Clean Fuels Inc
12/19/20247:00AMGlobeNewswire Inc.AleAnna Announces Signing of Gas Sale Contract with Shell Energy EuropeNASDAQ:ANNAAleAnna Inc
12/19/20247:00AMGlobeNewswire Inc.Tilray Brands, Inc. to Announce Second Quarter Fiscal Year 2025 Financial Results on January 9, 2025NASDAQ:TLRYTilray Brands Inc
12/19/20247:00AMGlobeNewswire Inc.Arbor Biotechnologies Announces FDA Acceptance of IND Application for ABO-101 for the Treatment of Primary Hyperoxaluria Type 1
12/19/20247:00AMBusiness WireExplorance Named Gold Winner for AI In Education Award by QS Reimagine Education Awards
12/19/20247:00AMBusiness WireKinaxis Announces $40,000 Academic Award to Empower the Next Generation of Supply Chain InnovatorsTSX:KXSKinaxis Inc
12/19/20247:00AMBusiness WireGetinge and 908 Devices Partner to Enhance Bioreactor Capabilities for Continuous Monitoring of Key Cell Culture ParametersNASDAQ:MASS908 Devices Inc
12/19/20247:00AMGlobeNewswire Inc.OTC Markets Group Welcomes Metaplanet Inc. to OTCQX3350
12/19/20247:00AMBusiness WireAdicet Bio Announces First Patient Dosed in the Phase 1 Clinical Trial of ADI-270 in Metastatic/Advanced Clear Cell Renal Cell CarcinomaNASDAQ:ACETAdicet Bio Inc
12/19/20247:00AMBusiness WireTAFE Urges AGCO to Address Critical Questions Regarding its Strategic Priorities During 2024 Analyst DayNYSE:AGCOAGCO Corp
12/19/20247:00AMBusiness WireProPetro Announces Contract for a 4th FORCE® Electric Hydraulic Fracturing FleetNYSE:PUMPProPetro Holding Corp
12/19/20247:00AMBusiness WireKKR Releases 2025 Global Macro OutlookNYSE:KKRKKR and Company Inc
12/19/20247:00AMGlobeNewswire Inc.FactSet Reports Results for First Quarter 2025NYSE:FDSNY^FDS
12/19/20247:00AMGlobeNewswire Inc.Western Investment Company Closes Outstanding $1.1 Million of the $30 Million Over-Subscribed Private PlacementTSXV:WIWestern Investment Company of Canada Limited

Your Recent History

TG
H5E
Helma Eigenheimbau
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads